Aki Sakurai

1.4k total citations
64 papers, 886 citations indexed

About

Aki Sakurai is a scholar working on Infectious Diseases, Epidemiology and Oncology. According to data from OpenAlex, Aki Sakurai has authored 64 papers receiving a total of 886 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 20 papers in Epidemiology and 17 papers in Oncology. Recurrent topics in Aki Sakurai's work include Antibiotic Resistance in Bacteria (10 papers), HIV/AIDS drug development and treatment (8 papers) and Drug Transport and Resistance Mechanisms (8 papers). Aki Sakurai is often cited by papers focused on Antibiotic Resistance in Bacteria (10 papers), HIV/AIDS drug development and treatment (8 papers) and Drug Transport and Resistance Mechanisms (8 papers). Aki Sakurai collaborates with scholars based in Japan, United States and Chile. Aki Sakurai's co-authors include Toshihisa Ishikawa, Yuko Onishi, Hiroyuki Hirano, Yohei Doi, Takuma Ishihara, Toshiharu Sasaki, Zenichi Morise, Shigeo Kato, Mitsunaga Iwata and Masamichi Hayashi and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Aki Sakurai

56 papers receiving 865 citations

Peers

Countries citing papers authored by Aki Sakurai

Since Specialization

Citations

This map shows the geographic impact of Aki Sakurai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aki Sakurai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aki Sakurai more than expected).

Fields of papers citing papers by Aki Sakurai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aki Sakurai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aki Sakurai. The network helps show where Aki Sakurai may publish in the future.

Co-authorship network of co-authors of Aki Sakurai

This figure shows the co-authorship network connecting the top 25 collaborators of Aki Sakurai. A scholar is included among the top collaborators of Aki Sakurai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aki Sakurai. Aki Sakurai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	In vitro activity of cefiderocol against carbapenem-resistant Gram-negative pathogens in Japan 2026 ·Journal of Infection and Chemotherapy ·(unknown), Aki Sakurai, (unknown), (unknown), Masahiro Suzuki, (unknown), Ryota Hase, Hideaki Kato, (unknown), Takashi Matono, (unknown), Momoko Mawatari, (unknown), Kayoko Hayakawa, (unknown), Yohei Doi	0
2	Molecular analysis of AmpC-producing Escherichia coli isolated from pediatric patients 2025 ·Journal of the Pediatric Infectious Diseases Society ·(unknown), Masahiro Suzuki, Aki Sakurai, Yohei Doi	0
3	Overcoming post‐transplant graft failure and adenovirus infection in a patient with FLT3‐TKD‐mutated mixed‐phenotype acute leukemia: A case report 2024 ·SHILAP Revista de lepidopterología ·(unknown), Shuhei Kurosawa, (unknown), Yuho Najima, Satoshi Wakita, Hiroki Yamaguchi, (unknown), (unknown), (unknown), Tsutomu Yoshida, (unknown), (unknown), Hitomi Nakayama, Aki Sakurai, (unknown), Yoshinobu Aisa, Tomonori Nakazato	1
4	The Real-World Outcomes of Relapsed/Refractory Multiple Myeloma Treated with Elotuzumab, Pomalidomide, and Dexamethasone 2024 ·SHILAP Revista de lepidopterología ·Hitomi Nakayama, Yoshinobu Aisa, (unknown), Aki Sakurai, Tomonori Nakazato	0
5	Pioneering cord blood transplantation in relapsed/refractory HIV-related lymphoma: a case study with concurrent intramuscular antiretroviral therapy 2024 ·International Journal of Infectious Diseases ·(unknown), Shuhei Kurosawa, Yukihiro Yoshimura, (unknown), (unknown), (unknown), (unknown), (unknown), Hitomi Nakayama, Aki Sakurai, (unknown), (unknown), Yoshinobu Aisa, Tomonori Nakazato	2
6	Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA 2022 ·JAC-Antimicrobial Resistance ·Truc T. Tran, (unknown), Anne J Gonzales-Luna, Travis J Carlson, (unknown), William R. Miller, Aki Sakurai, An Q Dinh, (unknown), Rafael Ríos, Lorena Díaz, Blake Hanson, José M. Munita, Claudia Pedroza, Samuel A. Shelburne, Samuel L Aitken, Kevin W. Garey, (unknown), Laura Puzniak, César A. Arias	3
7	Native valve infective endocarditis due to sequence type 97 community-associated methicillin-resistant Staphylococcus aureus complicated by meningitis and multiple septic emboli in a young healthy adult 2022 ·Journal of Infection and Chemotherapy ·(unknown), Aki Sakurai, Toshiharu Sasaki, Makoto Hasegawa, Masahiro Suzuki, (unknown), (unknown), (unknown), Yohei Doi	2
8	The prognostic value of the Fibrinogen-Albumin Ratio Index in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine 2021 ·Annals of Hematology ·(unknown), Aki Sakurai, (unknown), (unknown), Yoshinobu Aisa, Tomonori Nakazato	3
9	Vagococcus fluvialis as a causative pathogen of bloodstream and decubitus ulcer infection: Case report and systematic review of the literature 2020 ·Journal of Infection and Chemotherapy ·Takahiro Matsuo, Nobuyoshi Mori, Fujimi Kawai, Aki Sakurai, (unknown), (unknown), Yuki Uehara, Keiichi Furukawa	18
10	Natural History of Asymptomatic SARS-CoV-2 Infection 2020 ·New England Journal of Medicine ·Aki Sakurai, Toshiharu Sasaki, Shigeo Kato, Masamichi Hayashi, (unknown), Takuma Ishihara, Mitsunaga Iwata, Zenichi Morise, Yohei Doi	168
11	Prognostic Impact of ABO Blood Group on Survival in Patients With Malignant Lymphoma 2019 ·Clinical Lymphoma Myeloma & Leukemia ·(unknown), (unknown), (unknown), Shinji Ogura, Aki Sakurai, (unknown), Yoshinobu Aisa, Tomonori Nakazato	4
12	Metronidazole-induced encephalopathy and cytotoxic lesion of the corpus callosum in a patient with diabetic foot infection 2019 ·International Journal of Infectious Diseases ·Takahiro Matsuo, Nobuyoshi Mori, Aki Sakurai, Jay Starkey, Keiichi Furukawa	0
13	Prognostic significance of hyperfibrinogenemia in patients with lower-risk myelodysplastic syndromes 2019 ·Annals of Hematology ·Shinji Ogura, (unknown), (unknown), (unknown), Aki Sakurai, Yuriko Fujita, (unknown), Yoshinobu Aisa, Tomonori Nakazato	2
14	Listeria monocytogenes meningitis 2018 ·Clinical Case Reports ·Takahiro Matsuo, Nobuyoshi Mori, Aki Sakurai, Keiichi Furukawa	1
15	Vertebral osteomyelitis as a rare manifestation of Lemierre’s syndrome 2017 ·IDCases ·Takahiro Matsuo, Nobuyoshi Mori, Aki Sakurai, (unknown), Keiichi Furukawa	1
16	Evaluation of an Automated Rapid Diagnostic Assay for Detection of Gram-Negative Bacteria and Their Drug-Resistance Genes in Positive Blood Cultures 2014 ·PLoS ONE ·Masayoshi Tojo, Takahiro Fujita, Yusuke Ainoda, Maki Nagamatsu, Kayoko Hayakawa, Kazuhisa Mezaki, Aki Sakurai, (unknown), Hirohisa Yazaki, (unknown), Tohru Miyoshi‐Akiyama, Kyoichi Totsuka, Teruo Kirikae, Norio Ohmagari	45
17	Correlation of axillary osmidrosis to a SNP in the ABCC11 gene determined by the Smart Amplification Process (SmartAmp) method 2009 ·Journal of Plastic Reconstructive & Aesthetic Surgery ·Yuki Inoue, (unknown), Yu Toyoda, Aki Sakurai, Toshihisa Ishikawa, Yuichiro Mitani, Yoshihide Hayashizaki, Yasushi Yoshimura, Hiroki Kurahashi, (unknown)	26
18	Ciliates use both variant and universal genetic codes: Evidence of omnipotent eRF1s in the class Litostomatea 2008 ·Gene ·(unknown), Aki Sakurai, Kazuki Saito, Koichi Ito, Kenji Ikehara, Terue Harumoto	5
19	High‐Speed Screening of Human ATP‐Binding Cassette Transporter Function and Genetic Polymorphisms: New Strategies in Pharmacogenomics 2005 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Toshihisa Ishikawa, Aki Sakurai, (unknown), Makoto Nagakura, Hiroyuki Hirano, (unknown), Kazunari Yamada, (unknown), Masato Kitajima	32
20	Functional Evaluation of ABCB1 (P-Glycoprotein) Polymorphisms: High-Speed Screening and Structure-Activity Relationship Analyses 2004 ·Drug Metabolism and Pharmacokinetics ·Toshihisa Ishikawa, Hiroyuki Hirano, Yuko Onishi, Aki Sakurai, (unknown)	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact